HS
HighVista Strategies Portfolio holdings
AUM
$408M
1-Year Est. Return
87.62%
1 Year Est. Return
+87.62%
AUM
$408M
AUM Growth
+$136M
(+50%)
Holding
175
Top Buys
| 1 | +$11.3M | |
| 2 | +$6.79M | |
| 3 | +$5.52M | |
| 4 |
Agios Pharmaceuticals
AGIO
|
+$5.02M |
| 5 |
Revolution Medicines
RVMD
|
+$5.02M |
Top Sells
| 1 | +$6.01M | |
| 2 | +$4.58M | |
| 3 | +$4.37M | |
| 4 |
HES
Hess
HES
|
+$4M |
| 5 |
AMED
Amedisys
AMED
|
+$3.86M |
Sector Composition
| 1 | Healthcare | 59% |
| 2 | Technology | 12.23% |
| 3 | Industrials | 6.97% |
| 4 | Financials | 4.42% |
| 5 | Consumer Discretionary | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
| $32.4M | 7.93% |
1,436,136
|
|
||
|
ABVX
2
Abivax
ABVX
$8.65B
| $15.7M | 3.84% |
184,468
+133,312
|
|
||
3
Merus
MRUS
$7.29B
| $12.6M | 3.08% |
133,321
+43,559
|
|
||
4
Viridian Therapeutics
VRDN
$3B
| $10.1M | 2.48% |
469,335
-15,224
|
|
||
|
5
Revolution Medicines
RVMD
$15.1B
| $8.19M | 2.01% |
175,448
+107,400
|
|
||
6
Protagonist Therapeutics
PTGX
$5.42B
| $8.08M | 1.98% |
121,682
+63,831
|
|
||
7
Nuvalent
NUVL
$8.21B
| $8.07M | 1.98% |
93,294
+42,834
|
|
||
8
Mineralys Therapeutics
MLYS
$3.13B
| $7.96M | 1.95% |
209,829
+59,691
|
|
||
9
Arcellx
ACLX
$4.16B
| $7.9M | 1.94% |
96,177
+60,463
|
|
||
|
10
Agios Pharmaceuticals
AGIO
$1.6B
| $7.84M | 1.92% |
195,298
+125,171
|
|
||
11
Cytokinetics
CYTK
$7.92B
| $7.31M | 1.79% |
132,930
+64,278
|
|
||
12
Insmed
INSM
$44B
| $7.19M | 1.76% |
49,949
+38,354
|
|
||
13
Cidara Therapeutics
CDTX
$6.92B
| $6.79M | 1.66% |
+70,904
|
|
||
14
Cogent Biosciences
COGT
$5.99B
| $6.64M | 1.63% |
462,405
+179,219
|
|
||
15
Structure Therapeutics
GPCR
$1.93B
| $6.61M | 1.62% |
236,236
+149,615
|
|
||
16
Amazon
AMZN
$2.48T
| $5.8M | 1.42% |
26,393
+7,500
|
|
||
|
SNDK
17
Sandisk
SNDK
$27.9B
| $5.32M | 1.31% |
47,451
+7,851
|
|
||
18
Enliven Therapeutics
ELVN
$1.23B
| $5.3M | 1.3% |
259,135
+117,619
|
|
||
19
Akero Therapeutics
AKRO
$4.49B
| $5.23M | 1.28% |
110,079
+50,086
|
|
||
20
Praxis Precision Medicines
PRAX
$4.67B
| $5.04M | 1.23% |
95,002
+27,714
|
|
||
21
Microsoft
MSFT
$3.58T
| $4.9M | 1.2% |
9,458
-800
|
|
||
22
Olema Pharmaceuticals
OLMA
$2.19B
| $4.28M | 1.05% |
437,179
+158,749
|
|
||
23
BridgeBio Pharma
BBIO
$14B
| $4.26M | 1.04% |
81,959
+14,460
|
|
||
24
Apogee Therapeutics
APGE
$5.09B
| $4.26M | 1.04% |
107,107
+62,055
|
|
||
25
Immunovant
IMVT
$3.98B
| $4.08M | 1% |
253,127
+70,319
|
|